Stock RVMD REVOLUTION MEDICINES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
37.25 USD -0.53% Intraday chart for Revolution Medicines, Inc. -7.34% +29.88%
May. 09 Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating MT
May. 08 Revolution Medicines Q1 Net Loss Narrows MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Revolution Medicines Q1 Net Loss Narrows
Revolution Medicines, Inc. Reiterates Earnings Guidance for the Full Year 2024
Revolution Medicines, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Aethon Therapeutics, Inc. Announces Collaboration with Revolution Medicines, Inc. to Discover and Develop Novel Aethon Antibody Programs
Revolution Medicines Insider Sold Shares Worth $805,652, According to a Recent SEC Filing
Revolution Medicines Files Mixed-Securities Shelf
Revolution Medicines Q4 Net Loss Widens, Revenue Drops
Revolution Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Revolution Medicines, Inc. Provides Earnings Guidance for Full Year 2024
Revolution Medicines, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Revolution Medicines Insider Sold Shares Worth $387,884, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $966,996, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $125,000, According to a Recent SEC Filing
Revolution Medicines Closes Acquisition of EQRx in All-Stock Deal
Revolution Medicines, Inc. Appoints Sandra J. Horning, M.D., as Member of the Board
Revolution Medicines, Inc. completed the acquisition of EQRx, Inc. from a group of shareholders.
Revolution Medicines, EQRx Stockholders Approve Merger
Revolution Medicines Q3 Loss Widens
Revolution Medicines, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Revolution Medicines, Inc. Provides Earnings Guidance for Full Year 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVMD Stock
  4. News Revolution Medicines, Inc.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW